🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 9 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/08/2017 12,32 14,35 12,32 13,36 +9,42% 16,48% 106.200
23/08/2017 12,54 12,59 12,00 12,21 -2,40% 4,70% 12.600
22/08/2017 12,64 12,64 12,20 12,51 +1,62% 3,48% 33.000
21/08/2017 11,99 12,32 11,57 12,31 +3,36% 6,26% 23.900
18/08/2017 12,02 12,18 11,87 11,91 -2,78% 2,58% 60.300
17/08/2017 12,10 12,44 12,10 12,25 +0,41% 2,81% 31.600
16/08/2017 12,00 12,99 12,00 12,20 +0,99% 8,25% 49.400
15/08/2017 12,50 12,55 11,65 12,08 -3,28% 7,20% 41.000
14/08/2017 11,19 12,68 11,01 12,49 +12,52% 14,92% 92.100
11/08/2017 10,56 11,38 10,48 11,10 +4,62% 8,52% 144.600
10/08/2017 10,75 10,83 10,26 10,61 -1,03% 5,32% 88.300
09/08/2017 11,53 11,82 10,38 10,72 -8,69% 12,49% 101.000
08/08/2017 11,64 12,02 11,55 11,74 +1,12% 4,04% 34.200
07/08/2017 11,87 11,89 11,50 11,61 -1,02% 3,29% 37.900
04/08/2017 10,88 11,92 10,88 11,73 +7,52% 9,57% 58.300
03/08/2017 11,52 11,52 10,87 10,91 -2,42% 5,64% 33.700
02/08/2017 11,98 11,98 11,01 11,18 -5,97% 8,10% 54.100
01/08/2017 12,44 12,59 11,43 11,89 -2,46% 9,30% 126.700
31/07/2017 12,60 12,65 12,10 12,19 -3,79% 4,37% 70.200
28/07/2017 13,07 13,07 12,56 12,67 -2,69% 3,90% 18.100
27/07/2017 13,63 13,92 12,65 13,02 -4,34% 9,31% 89.900
26/07/2017 13,41 13,79 13,13 13,61 +2,79% 4,92% 112.000
25/07/2017 13,52 13,72 13,04 13,24 -1,19% 5,02% 31.700
24/07/2017 12,84 13,46 12,38 13,40 +5,10% 8,45% 155.300
21/07/2017 13,80 13,80 12,58 12,75 -1,32% 8,84% 107.200
20/07/2017 12,82 13,15 12,38 12,92 +0,00% 6,01% 123.400
19/07/2017 12,26 12,96 12,25 12,92 +5,38% 5,79% 115.100
18/07/2017 12,64 12,69 12,25 12,26 -3,16% 3,47% 48.200
17/07/2017 13,54 13,80 12,54 12,66 -6,64% 9,31% 46.600
14/07/2017 14,07 14,07 13,35 13,56 -2,66% 5,12% 83.300